Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Sex-dependent association of circulating sex steroids and pituitary hormones with treatment-free survival in chronic lymphocytic leukemia patients.

Allain EP, Venzl K, Caron P, Turcotte V, Simonyan D, Gruber M, Le T, Lévesque E, Guillemette C, Vanura K.

Ann Hematol. 2018 Sep;97(9):1649-1661. doi: 10.1007/s00277-018-3356-z. Epub 2018 May 21.

2.

Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation.

Freund P, Porpaczy EA, Le T, Gruber M, Pausz C, Staber P, Jäger U, Vanura K.

PLoS One. 2016 Jun 1;11(6):e0156693. doi: 10.1371/journal.pone.0156693. eCollection 2016.

3.

Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K/AKT, FOXO1 and MYC, and can be targeted by SYK inhibition.

Köhrer S, Havranek O, Seyfried F, Hurtz C, Coffey GP, Kim E, Ten Hacken E, Jäger U, Vanura K, O'Brien S, Thomas DA, Kantarjian H, Ghosh D, Wang Z, Zhang M, Ma W, Jumaa H, Debatin KM, Müschen M, Meyer LH, Davis RE, Burger JA.

Leukemia. 2016 Jun;30(6):1246-54. doi: 10.1038/leu.2016.9. Epub 2016 Feb 5.

4.

Impact of Single or Combined Genomic Alterations of TP53, MYC, and BCL2 on Survival of Patients With Diffuse Large B-Cell Lymphomas: A Retrospective Cohort Study.

Schiefer AI, Kornauth C, Simonitsch-Klupp I, Skrabs C, Masel EK, Streubel B, Vanura K, Walter K, Migschitz B, Stoiber D, Sexl V, Raderer M, Chott A, da Silva MG, Cabecadas J, Müllauer L, Jäger U, Porpaczy E.

Medicine (Baltimore). 2015 Dec;94(52):e2388. doi: 10.1097/MD.0000000000002388.

5.

SAR-guided development and characterization of a potent antitumor compound toward B-cell neoplasms with no detectable cytotoxicity toward healthy cells.

Brunhofer-Bolzer G, Le T, Dyckmanns N, Knaus HA, Pausz C, Freund P, Jäger U, Erker T, Vanura K.

J Med Chem. 2015 Feb 12;58(3):1244-53. doi: 10.1021/jm501848m. Epub 2015 Jan 20.

PMID:
25562417
6.

Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma.

Gebhart J, Lechner K, Skrabs C, Sliwa T, Müldür E, Ludwig H, Nösslinger T, Vanura K, Stamatopoulos K, Simonitsch-Klupp I, Chott A, Quehenberger P, Mitterbauer-Hohendanner G, Pabinger I, Jäger U, Geissler K.

Thromb Res. 2014 Nov;134(5):980-4. doi: 10.1016/j.thromres.2014.08.021. Epub 2014 Aug 29.

PMID:
25201005
7.

The Runx-PU.1 pathway preserves normal and AML/ETO9a leukemic stem cells.

Staber PB, Zhang P, Ye M, Welner RS, Levantini E, Di Ruscio A, Ebralidze AK, Bach C, Zhang H, Zhang J, Vanura K, Delwel R, Yang H, Huang G, Tenen DG.

Blood. 2014 Oct 9;124(15):2391-9. doi: 10.1182/blood-2014-01-550855. Epub 2014 Sep 3.

8.

Chronic lymphocytic leukemia patients have a preserved cytomegalovirus-specific antibody response despite progressive hypogammaglobulinemia.

Vanura K, Rieder F, Kastner MT, Biebl J, Sandhofer M, Le T, Strassl R, Puchhammer-Stöckl E, Perkmann T, Steininger CF, Stamatopoulos K, Graninger W, Jäger U, Steininger C.

PLoS One. 2013 Oct 23;8(10):e78925. doi: 10.1371/journal.pone.0078925. eCollection 2013.

9.

UDP-glucuronosyltransferase 2B17 genotype and the risk of lung cancer among Austrian Caucasians.

Gruber M, Le T, Filipits M, Gsur A, Mannhalter C, Jäger U, Vanura K.

Cancer Epidemiol. 2013 Oct;37(5):625-8. doi: 10.1016/j.canep.2013.06.004. Epub 2013 Jul 11.

PMID:
23850147
10.

Lipoprotein lipase in chronic lymphocytic leukaemia - strong biomarker with lack of functional significance.

Porpaczy E, Tauber S, Bilban M, Kostner G, Gruber M, Eder S, Heintel D, Le T, Fleiss K, Skrabs C, Shehata M, Jäger U, Vanura K.

Leuk Res. 2013 Jun;37(6):631-6. doi: 10.1016/j.leukres.2013.02.008. Epub 2013 Mar 7.

11.

Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia.

Gruber M, Bellemare J, Hoermann G, Gleiss A, Porpaczy E, Bilban M, Le T, Zehetmayer S, Mannhalter C, Gaiger A, Shehata M, Fleiss K, Skrabs C, Lévesque É, Vanura K, Guillemette C, Jaeger U.

Blood. 2013 Feb 14;121(7):1175-83. doi: 10.1182/blood-2012-08-447359. Epub 2012 Nov 20.

12.

Recombinant antibodies encoded by IGHV1-69 react with pUL32, a phosphoprotein of cytomegalovirus and B-cell superantigen.

Steininger C, Widhopf GF 2nd, Ghia EM, Morello CS, Vanura K, Sanders R, Spector D, Guiney D, Jäger U, Kipps TJ.

Blood. 2012 Mar 8;119(10):2293-301. doi: 10.1182/blood-2011-08-374058. Epub 2012 Jan 10.

13.

Prolonged progression-free survival in patients with chronic lymphocytic leukemia receiving granulocyte colony-stimulating factor during treatment with fludarabine, cyclophosphamide, and rituximab.

Gruber M, Fleiss K, Porpaczy E, Skrabs C, Hauswirth AW, Gaiger A, Vanura K, Heintel D, Shehata M, Einberger C, Thalhammer R, Fonatsch C, Jäger U.

Ann Hematol. 2011 Oct;90(10):1131-6. doi: 10.1007/s00277-011-1260-x. Epub 2011 May 27.

PMID:
21617923
14.

Prevalence and clinical impact of autoimmune diseases and chronic infections in malignant lymphomas at diagnosis.

Vanura K, Späth F, Gleiss A, Le T, Porpaczy E, Skrabs C, Hauswirth A, Fleiss K, Wessely F, Gaiger A, Müllauer L, Jäger U.

Ann Hematol. 2011 Aug;90(8):947-54. doi: 10.1007/s00277-011-1178-3. Epub 2011 Feb 17.

PMID:
21327940
15.

Sequential gene expression profiling during treatment for identification of predictive markers and novel therapeutic targets in chronic lymphocytic leukemia.

Shehata M, Demirtas D, Schnabl S, Hilgarth M, Hubmann R, Fonatsch C, Schwarzinger I, Hopfinger G, Eigenberger K, Heintel D, Porpaczy E, Vanura K, Hauswirth A, Schwarzmeier JD, Gaiger A, Stilgenbauer S, Hallek M, Bilban M, Jäger U.

Leukemia. 2010 Dec;24(12):2122-7. doi: 10.1038/leu.2010.220. Epub 2010 Oct 22. No abstract available.

PMID:
20966934
16.

NOTCH2 links protein kinase C delta to the expression of CD23 in chronic lymphocytic leukaemia (CLL) cells.

Hubmann R, Düchler M, Schnabl S, Hilgarth M, Demirtas D, Mitteregger D, Hölbl A, Vanura K, Le T, Look T, Schwarzmeier JD, Valent P, Jäger U, Shehata M.

Br J Haematol. 2010 Mar;148(6):868-78. doi: 10.1111/j.1365-2141.2009.08024.x. Epub 2009 Dec 8.

PMID:
19995395
17.

Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia.

Steininger C, Rassenti LZ, Vanura K, Eigenberger K, Jäger U, Kipps TJ, Mannhalter C, Stilgenbauer S, Popow-Kraupp T.

Eur J Clin Invest. 2009 Jun;39(6):497-506. doi: 10.1111/j.1365-2362.2009.02131.x.

18.

V(D)J targeting mistakes occur at low frequency in acute lymphoblastic leukemia.

Vanura K, Vrsalovic MM, Le T, Marculescu R, Kusec R, Jäger U, Nadel B.

Genes Chromosomes Cancer. 2009 Aug;48(8):725-36. doi: 10.1002/gcc.20677.

PMID:
19455608
19.

Gene expression signature of chronic lymphocytic leukaemia with Trisomy 12.

Porpaczy E, Bilban M, Heinze G, Gruber M, Vanura K, Schwarzinger I, Stilgenbauer S, Streubel B, Fonatsch C, Jaeger U.

Eur J Clin Invest. 2009 Jul;39(7):568-75. doi: 10.1111/j.1365-2362.2009.02146.x. Epub 2009 Apr 30.

PMID:
19453646
20.

Autoimmune conditions and chronic infections in chronic lymphocytic leukemia patients at diagnosis are associated with unmutated IgVH genes.

Vanura K, Le T, Esterbauer H, Späth F, Porpaczy E, Shehata M, Eigenberger K, Hauswirth A, Skrabs C, Krömer E, Schwarzinger I, Streubel B, Steininger C, Fonatsch C, Stilgenbauer S, Wagner O, Gaiger A, Jäger U.

Haematologica. 2008 Dec;93(12):1912-6. doi: 10.3324/haematol.12955. Epub 2008 Oct 6.

Supplemental Content

Loading ...
Support Center